Correction to: MiR-10a-5p targets TFAP2C to promote gemcitabine resistance in pancreatic ductal adenocarcinoma

Correction to: J Exp Clin Cancer Res 37, 76 (2018)

https://doi.org/10.1186/s13046-018-0739-x

Following publication of the original article [1], the authors identified minor errors in Fig. 2; specifically, in Fig. 2b, in the fourth group, the invasion, SU86.86, inhibitor images have been replaced with the correct images.

Fig. 2.

MiR-10a-5p promotes PDAC cell migration and invasion. a MiR-10a-5p overexpression promoted T3M4 and AsPC-1 cell migration, while miR-10a-5p knockdown decreased Su86.86 and AsPC-1 cell migration; b miR-10a-5p overexpression promoted T3M4 and AsPC-1 cell invasion, while miR-10a-5p knockdown decreased Su86.86 and AsPC-1 cell invasion; c miR-10a-5p expression up-regulation decreased E-cadherin and Caudin-1 protein levels while increasing Vimentin, Slug and Snail levels, as determined by using western blotting. d The relative intensity of the grayscale band values revealed the changes with miR-10a-5p overexpression or knockdown in PDAC cells; the data are presented as the means ± SD (Student’s t-test; *, P < 0.05)

The corrected figure is provided here. The correction does not have any effect on the results or conclusions of the paper. The original article has been corrected.